Overview
Clinical Benefits
- Site-specific muscle growth
- Stronger local anabolic effect than IGF-1 LR3
- Rapid action
- Less systemic side effects
Administration
Intramuscular injection directly into target muscle
Drug class: igf analog
Clinical Dosing
Typical dosage
50-150mcg per injection
Starting dose
50mcg
Cadence
Once daily (pre- or post-workout, into target muscle)
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-2 | 50mcg pre-workout into target muscle |
| Weeks 3-4 | 75-100mcg pre-workout |
| Weeks 5+ | Cycle off 4-6 weeks |
Safety Profile
Side effects
- • Hypoglycemia
- • Injection site soreness
- • Lightheadedness
Contraindications
- • Active cancer
- • Diabetes
- • Pregnancy
Frequently asked questions
IGF-1 DES (1-3) is most commonly researched for: Site-specific muscle growth, Stronger local anabolic effect than IGF-1 LR3, Rapid action, Less systemic side effects.
Ready to build a protocol with IGF-1 DES (1-3)?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.